101 related articles for article (PubMed ID: 17297449)
1. Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.
Chen M; Rahman L; Voeller D; Kastanos E; Yang SX; Feigenbaum L; Allegra C; Kaye FJ; Steeg P; Zajac-Kaye M
Oncogene; 2007 Jul; 26(33):4817-24. PubMed ID: 17297449
[TBL] [Abstract][Full Text] [Related]
2. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of thymidylate synthase linked to neoplastic transformation of mammalian cells.
Voeller D; Rahman L; Zajac-Kaye M
Cell Cycle; 2004 Aug; 3(8):1005-7. PubMed ID: 15280655
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival.
Vijayakurup V; Maeng K; Lee HS; Meyer B; Burkett S; Nawab A; Dougherty MW; Jobin C; Mahmud I; Garrett TJ; Feely M; Lee KB; Kaye FJ; Guijarro MV; Zajac-Kaye M
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36048542
[TBL] [Abstract][Full Text] [Related]
5. Induction of angiogenesis during the transition from hyperplasia to neoplasia.
Folkman J; Watson K; Ingber D; Hanahan D
Nature; 1989 May; 339(6219):58-61. PubMed ID: 2469964
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia.
Petrik J; Pell JM; Arany E; McDonald TJ; Dean WL; Reik W; Hill DJ
Endocrinology; 1999 May; 140(5):2353-63. PubMed ID: 10218989
[TBL] [Abstract][Full Text] [Related]
7. [Morphogenetic study on hyperplastic and neoplastic diseases of endocrine pancreas].
Jiang CX; Tan YB
Zhonghua Bing Li Xue Za Zhi; 1990 Sep; 19(3):175-8. PubMed ID: 2177685
[TBL] [Abstract][Full Text] [Related]
8. Pathology of the endocrine pancreas.
Heitz PU; Kasper M; Polak JM; Klöppel G
J Histochem Cytochem; 1979 Oct; 27(10):1401-2. PubMed ID: 229158
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors.
Fendrich V; Rehm J; Waldmann J; Buchholz M; Christofori G; Lauth M; Slater EP; Bartsch DK
Ann Surg; 2011 Mar; 253(3):546-52. PubMed ID: 21239987
[TBL] [Abstract][Full Text] [Related]
10. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors.
Tomita T; Iwata K
Mod Pathol; 1997 Jan; 10(1):47-54. PubMed ID: 9021726
[TBL] [Abstract][Full Text] [Related]
11. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Memoli VA; Longnecker DS
Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.
Hu YC; Komorowski RA; Graewin S; Hostetter G; Kallioniemi OP; Pitt HA; Ahrendt SA
Clin Cancer Res; 2003 Sep; 9(11):4165-71. PubMed ID: 14519641
[TBL] [Abstract][Full Text] [Related]
13. [Endocrine component of exocrine pancreatic tumors. Apropos of 2 cases].
Kusielewicz D; Houry S; Sabourin JC; Georges O; Roland J; Huguier M; Bodin F
Ann Gastroenterol Hepatol (Paris); 1992; 28(1):12-6. PubMed ID: 1313217
[TBL] [Abstract][Full Text] [Related]
14. Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature.
Yu R; Nissen NN; Dhall D; Heaney AP
Pancreas; 2008 May; 36(4):428-31. PubMed ID: 18437091
[TBL] [Abstract][Full Text] [Related]
15. Endocrine tumors of the pancreas: the pathologist's approach.
Bordi C
Acta Biomed Ateneo Parmense; 1993; 64(5-6):195-204. PubMed ID: 7992557
[TBL] [Abstract][Full Text] [Related]
16. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.
Correale P; Del Vecchio MT; Di Genova G; Savellini GG; La Placa M; Terrosi C; Vestri M; Urso R; Lemonnier F; Aquino A; Bonmassar E; Giorgi G; Francini G; Cusi MG
J Natl Cancer Inst; 2005 Oct; 97(19):1437-45. PubMed ID: 16204693
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the Sm-like proto-oncogene in primary and metastatic pancreatic endocrine tumors.
Gumbs AA; Bassi C; Moore PS; Falconi M; Frigerio I; Baron A; Piemonti L; Modlin I; Scarpa A
JOP; 2002 Jul; 3(4):109-15. PubMed ID: 12110768
[TBL] [Abstract][Full Text] [Related]
18. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
19. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.
Crabtree JS; Scacheri PC; Ward JM; Garrett-Beal L; Emmert-Buck MR; Edgemon KA; Lorang D; Libutti SK; Chandrasekharappa SC; Marx SJ; Spiegel AM; Collins FS
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1118-23. PubMed ID: 11158604
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia.
Means AL; Ray KC; Singh AB; Washington MK; Whitehead RH; Harris RC; Wright CV; Coffey RJ; Leach SD
Gastroenterology; 2003 Apr; 124(4):1020-36. PubMed ID: 12671899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]